论文部分内容阅读
为了确定适用于非何杰氏淋巴瘤诊断的免疫表现型诊断标准,本文用多种单克隆抗体检测一大批经病理组织学证实为良性和恶性组织增生性病变的免疫组织化学形态变化.作者认为该诊断标准是可靠的,只要采用这些方法对病例进行免疫构型特征的分析,不依靠常规的形态学就可以明确区别良恶性淋巴组织病变.一般而言,
In order to determine the diagnostic criteria for immunophenotyping applicable to the diagnosis of non-Hodgkin’s lymphoma, we used a variety of monoclonal antibodies to detect a large number of immunohistochemical changes in the histopathology of benign and malignant tissue proliferative lesions. The diagnostic criteria are reliable, as long as the use of these methods to analyze the characteristics of the immune configuration of cases, do not rely on conventional morphology can clearly distinguish between benign and malignant lymphoid lesions.In general,